Symvess™ is the first and only acellular tissue-engineered vessel for urgent revascularization of extremity arterial injuries when an autologous vein graft isn’t feasible. Implanted to repair damaged arteries and restore blood flow, it gradually repopulates with the patient’s own cells - transforming from an engineered conduit into a living vessel.

Early name explorations highlighted speed, healing, and vascular strength. The team ultimately chose Symvess™ for its balance of science and empathy: “Sym” evokes symbiosis, sympathy, and synchrony, capturing how the vessel works in harmony with the patient’s tissue, while “Vess” grounds the name in its vascular purpose. Short, modern, and memorable, Symvess™ signals innovation, reliability, and life-saving performance at the moment it matters most.

Partner: Toggle Marketing, LLC